| B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) (NCT04897321) | St. Jude Children's Research Hospital | 2022-07-06 |
| An Observational Study of Local Relapse After High Grade Osteosarcoma (NCT06017518) | Istituto Ortopedico Rizzoli | 2022-06-13 |
| A Phase I Feasibility And Safety Study of Fluorescein-Specific (FITC-E2) CAR T Cells In Combination With Parenterally Administered Folate-Fluorescein (UB-TT170) For Osteogenic Sarcoma (NCT05312411) | Seattle Children's Hospital | 2022-05-20 |
| Regorafenib in Patients With Refractory Primary Bone Tumors (NCT05395741) | Institute of Mother and Child, Warsaw, Poland | 2022-04-28 |
| Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas (NCT05182164) | Institut Bergonié | 2022-04-25 |
| Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma (NCT05235165) | Children's Oncology Group | 2022-04-01 |
| Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma (NCT05116800) | Brown University | 2022-03-01 |
| Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors (NCT05302921) | Children's National Research Institute | 2022-02-18 |
| Prehabilitation to Improve Cancer Surgery Outcomes in AYA Patients With Extremity Sarcomas (NCT04248959) | University Health Network, Toronto | 2022-02-02 |
| Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors (NCT05057130) | Blokhin's Russian Cancer Research Center | 2022-01-10 |
| HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma (NCT04995003) | Baylor College of Medicine | 2021-12-07 |
| A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors (NCT05093322) | Hutchmed | 2021-11-30 |
| Efficacy of Epidural Analgesia in Lower Extremity Osteosarcoma (NCT04945512) | Istanbul University | 2021-11-07 |
| Efficacy of Exercise Program on Osteosarcoma Patients (NCT04757064) | Cairo University | 2021-08-07 |
| Perioperative Use of Tranexamic (TXA) in Bone Tumor Surgery Will Change in Blood Loss and Transfusion Requirements. (NCT05024253) | Children's Cancer Hospital Egypt 57357 | 2021-08-02 |
| Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients (NCT04698785) | Centre Leon Berard | 2021-07-21 |
| The Prognostic Value of Serum Biomarkers in Osteosarcoma (NCT05093101) | Istituto Ortopedico Rizzoli | 2021-07-12 |
| SARC038: Phase 2 Study of Regorafenib and Nivolumab in Osteosarcoma (NCT04803877) | Sarcoma Alliance for Research through Collaboration | 2021-06-04 |
| IBI188 Combination Therapy in Solid Tumors (NCT04861948) | Innovent Biologics (Suzhou) Co. Ltd. | 2021-05-25 |
| Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid Tumor (NCT04864821) | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2021-05-14 |
| The Registry of Oncology Outcomes Associated With Testing and Treatment (NCT04028479) | Taproot Health | 2021-05-05 |
| A Study to Evaluate the Safety and Efficacy of ALMB-0168 in Patients With Osteosarcoma (NCT04886765) | AlaMab Therapeutics (Shanghai) Inc. | 2021-05-01 |
| Dietary Habits, Metabolome, Immune Profile and Microbiota in Patients With Bone Sarcoma (NCT04735289) | Istituto Ortopedico Rizzoli | 2021-03-10 |
| Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor (NCT04616560) | National Cancer Institute (NCI) | 2021-03-08 |
| Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse (NCT04758000) | Istituto Ortopedico Rizzoli | 2021-03-01 |
| 18F-FTC-146 PET/CT in Newly-Diagnosed Osteosarcoma (NCT04365660) | Davidzon, Guido, M.D. | 2021-01-28 |
| Predictive Models of Treatment Responses and Survival Outcomes in Patients With Osteosarcoma (NCT05194605) | West China Hospital | 2021-01-01 |
| A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors. (NCT04671693) | Centre Leon Berard | 2020-12-24 |
| Olaparib With Ceralasertib in Recurrent Osteosarcoma (NCT04417062) | Dana-Farber Cancer Institute | 2020-11-24 |
| Drug Sensitivity and Mutation Profiling (NCT04956198) | Florida International University | 2020-11-17 |
| Construction of Microfluidic Exosome Chip for Diagnosis of Lung Metastasis of Osteosarcoma (NCT05101655) | Ruijin Hospital | 2020-10-01 |
| Phase II Clinical Trial Scheme of Ganoderma Lucidum Spore Powder for Postoperative Chemotherapy of Osteosarcoma (NCT04319874) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2020-09-15 |
| A Phase I Clinical Trial of Neoadjuvant Chemotherapy With/Without SPIONs/SMF for Patients With Osteosarcoma (NCT04316091) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2020-09-01 |
| B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults (NCT04483778) | Seattle Children's Hospital | 2020-07-13 |
| Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma (NCT04351308) | Peking University People's Hospital | 2020-05-01 |
| A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma (NCT04154189) | Eisai Inc. | 2020-03-23 |
| Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas (NCT04055220) | Centre Leon Berard | 2020-03-03 |
| Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of Osteosarcoma (NCT04294511) | Sun Yat-sen University | 2019-12-26 |
| ICONIC: Improving Outcomes Through Collaboration in OsteosarComa (NCT04132895) | University College, London | 2019-10-25 |
| Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration (NCT04040205) | Medical College of Wisconsin | 2019-10-07 |
| Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma (NCT03628209) | H. Lee Moffitt Cancer Center and Research Institute | 2019-10-03 |
| Cancer Genome Study Using Samples From Patients Treated on Clinical Trial SHR1020-SHR-1210-II-OS (NCT03997747) | Peking University People's Hospital | 2019-08-13 |
| Pulmonary Resectable Metastases of Osteosarcoma With Anti-angiogenics and CHemotherapy (NCT03742193) | Ruijin Hospital | 2019-08-11 |
| EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults (NCT03618381) | Seattle Children's Hospital | 2019-06-18 |
| Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas (NCT03478462) | Cellectar Biosciences, Inc. | 2019-04-30 |
| Glucarpidase After High-Dose Methotrexate in Patients With Osteosarcoma (NCT03960177) | OHSU Knight Cancer Institute | 2019-03-27 |
| Study of the Safety and Efficacy of Humanized 3F8 Bispecific Antibody (Hu3F8-BsAb) in Patients With Relapsed/Refractory Neuroblastoma, Osteosarcoma and Other Solid Tumor Cancers (NCT03860207) | Y-mAbs Therapeutics | 2019-02-22 |
| Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma (NCT03721068) | UNC Lineberger Comprehensive Cancer Center | 2019-02-19 |
| M6620 (VX-970) in Selected Solid Tumors (NCT03718091) | Massachusetts General Hospital | 2019-01-08 |
| Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma Patients (NCT03643133) | UNICANCER | 2018-10-23 |
| A Clinical Study of PD-L1 Antibody ZKAB001(Drug Code) in Limited Stage of High-grade Osteosarcoma (NCT03676985) | Lee's Pharmaceutical Limited | 2018-10-10 |
| Proteomics Research of Osteosarcoma (NCT03932058) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2018-09-01 |
| Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients (NCT03458728) | Bayer | 2018-04-30 |
| Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO) (NCT03496402) | Institut Curie | 2018-04-20 |
| Treatment of Relapsed or Refractory Neuroblastoma and Osteosarcoma With Expanded Haploidentical NK Cells and Hu14.18-IL2 (NCT03209869) | University of Wisconsin, Madison | 2018-03-12 |
| Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas (NCT03442465) | Memorial Sloan Kettering Cancer Center | 2018-02-14 |
| Pediatric PET/MR Image Registry (NCT03458520) | Stanford University | 2018-02-01 |
| Patient-derived Xenograft (PDX) Modeling to Test Drug Response for High-grade Osteosarcoma (NCT03358628) | Peking University People's Hospital | 2018-02-01 |
| Feasibility Study of Interval Compressed Regimen Using Four-drugs for Osteosarcoma (NCT03390946) | Byung-Kiu Park | 2018-02-01 |
| The Osteosarcoma Biobank in Peking University People's Hospital (NCT03362086) | Peking University People's Hospital | 2018-02-01 |
| Anti-GD2 CAR T Cells in Pediatric Patients Affected by High Risk and/or Relapsed/Refractory Neuroblastoma or Other GD2-positive Solid Tumors (NCT03373097) | Bambino Gesù Hospital and Research Institute | 2018-01-05 |
| Osteosarcoma in Patients Older Than 40 Years. Prognostic Factors and Survival (NCT03911245) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2018-01-01 |
| Biospecimen Analysis in Determining Effects of Chemotherapy on Fertility in Osteosarcoma Survivors (NCT03206450) | Children's Oncology Group | 2017-12-06 |
| Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies (NCT03422679) | Cellestia Biotech AG | 2017-12-05 |
| A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma (NCT02982486) | Assaf-Harofeh Medical Center | 2017-12-01 |
| Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial) (NCT03220035) | National Cancer Institute (NCI) | 2017-11-08 |
| A Study of Pembrolizumab in Patients With Relapsed Or Metastatic Osteosarcoma Not Eligible for Curative Surgery (NCT03013127) | Oslo University Hospital | 2017-05-30 |
| Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors (NCT02867592) | National Cancer Institute (NCI) | 2017-05-18 |
| Circulating Exosome RNA in Lung Metastases of Primary High-Grade Osteosarcoma (NCT03108677) | Ruijin Hospital | 2017-05-01 |
| Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression. (NCT03242382) | Grupo Espanol de Investigacion en Sarcomas | 2017-03-31 |
| A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma (NCT03006848) | St. Jude Children's Research Hospital | 2017-02-16 |
| Biology of Osteosarcoma (BOOST) Registry and Biobank (NCT03225872) | University of Minnesota | 2017-01-03 |
| Clinical Trial Evaluating Metronomic Chemotherapy in Patients With Metastatic Osteosarcoma (NCT03063983) | Grupo de Apoio ao Adolescente e a Crianca com Cancer | 2017-01-02 |
| Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors (NCT02581384) | Dana-Farber Cancer Institute | 2017-01-01 |
| HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors (NCT02557854) | Theodore Laetsch | 2016-12-01 |
| Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors (NCT02982941) | MacroGenics | 2016-12-01 |
| Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer (NCT02856048) | Assistance Publique - Hôpitaux de Paris | 2016-11-23 |
| Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma (NCT02945800) | H. Lee Moffitt Cancer Center and Research Institute | 2016-10-25 |
| A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors (NCT02536183) | AeRang Kim | 2016-10-01 |
| Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors (NCT02689336) | Washington University School of Medicine | 2016-08-06 |
| Phase II Trial for the Treatment of Relapsed Osteosarcoma (NCT02718482) | Italian Sarcoma Group | 2016-04-06 |
| NAC to Prevent Cisplatin-induced Hearing Loss (NCT02094625) | Children's Hospital Los Angeles | 2016-03-01 |
| Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal Therapy (NCT02711007) | GUO WEI | 2016-03-01 |
| Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors (NCT02508038) | University of Wisconsin, Madison | 2016-02-12 |
| Diffusion Weighted Magnetic Resonance in Imaging Younger Patients With Newly Diagnosed Bone or Soft Tissue Sarcomas (NCT02415816) | St. Jude Children's Research Hospital | 2015-06-05 |
| Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors (NCT02390843) | Emory University | 2015-02-01 |
| Metronomic Chemotherapy in Patients With Advanced Solid Tumor With Bone Metastasis and Advanced Pretreated Osteosarcoma (NCT02517918) | Institut Bergonié | 2015-02-01 |
| Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma (NCT02432274) | Eisai Limited | 2014-12-29 |
| Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies (NCT02223052) | Celgene | 2014-10-27 |
| A Eurosarc Study of Mifamurtide in Advanced Osteosarcoma (MEMOS) (NCT02441309) | University of Oxford | 2014-10-01 |
| Pretreatment Anti-Therapeutic Antibodies (PATA) in Patients Treated With hu14.18K322A Antibody (NCT02159443) | St. Jude Children's Research Hospital | 2014-07-15 |
| ABCB1/P-glycoprotein Expression Influence on Non-metastatic Osteosarcoma of the Extremities (NCT04383288) | Grupo Espanol de Investigacion en Sarcomas | 2014-07-02 |
| iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma (NCT01953900) | Baylor College of Medicine | 2014-04-01 |
| MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors (NCT02076906) | AeRang Kim | 2014-04-01 |
| Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment (NCT01790152) | Children's Oncology Group | 2014-03-05 |
| A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With GD2+ Solid Tumors (NCT02107963) | National Cancer Institute (NCI) | 2014-02-28 |
| Cryoablation, Radiofrequency Ablation, or Microwave Ablation in Treating Patients With Metastatic Sarcoma Stable on Chemotherapy (NCT01986829) | Washington University School of Medicine | 2014-02-03 |
| Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors (NCT02013336) | South Plains Oncology Consortium | 2013-12-01 |
| Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer (NCT01987596) | Barbara Ann Karmanos Cancer Institute | 2013-08-01 |
| Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid Tumors (NCT01807468) | Samsung Medical Center | 2013-05-01 |